Menu Search
Equities

Zeria Pharmaceutical Co Ltd

4559:TYO

Zeria Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)2,231.00
  • Today's Change8.00 / 0.36%
  • Shares traded28.50k
  • 1 Year change-3.84%
  • Beta0.3270
Data delayed at least 20 minutes, as of Sep 20 2024 02:01 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income9,5087,2735,722
Depreciation/depletion6,3415,4314,701
Non-Cash items(1702)169439
Cash taxes paid, supplemental916564875
Cash interest paid, supplemental447301305
Changes in working capital(3178)(433)(2481)
Total cash from operations12,18413,1579,080
INVESTING
Capital expenditures(3899)(2658)(1421)
Other investing and cash flow items, total(54)83(1472)
Total cash from investing(3952)(2575)(2893)
FINANCING
Financing cash flow items(1.49)(3.93)(3.52)
Total cash dividends paid(1935)(1590)(1538)
Issuance (retirement) of stock, net(0.82)(674)(2603)
Issuance (retirement) of debt, net(6186)(5147)(696)
Total cash from financing(8124)(7415)(4841)
NET CHANGE IN CASH
Foreign exchange effects2,4031,347564
Net change in cash2,5104,5151,910
Net cash-begin balance/reserved for future use16,09411,5799,669
Net cash-end balance/reserved for future use18,60416,09411,579
SUPPLEMENTAL INCOME
Depreciation, supplemental6,3415,4314,701
Cash interest paid, supplemental447301305
Cash taxes paid, supplemental916564875
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.